Jakob Dupont's Net Worth
$3.4 Million
Who is Jakob Dupont?
Jakob Dupont has an estimated net worth of $3.4 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., Gossamer Bio, Inc., Apexigen, Inc., OncoMed Pharmaceuticals Inc, Pyxis Oncology, Inc., and Bolt Biotherapeutics, Inc..
SEC CIK
Jakob Dupont's CIK is 0001553335
Past Insider Trading and Trends
2023 was Jakob Dupont's most active year for acquiring shares with 6 total transactions. Jakob Dupont's most active month to acquire stocks was the month of February. 2022 was Jakob Dupont's most active year for disposing of shares, totalling 9 transactions. Jakob Dupont's most active month to dispose stocks was the month of November. 2019 saw Jakob Dupont paying a total of $449,755.74 for 106,994 shares, this is the most they've acquired in one year. In 2019 Jakob Dupont cashed out on 83,988 shares for a total of $631,538.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $9.1465
EVP, Head R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.71% | -5.07K |
$3.63 | -$18,403.40 | 290.79K |
Scheduled
|
Mar 2
| ||
Form 4
| +91.45% | 141.33K |
—
|
—
| 295.87K |
Mar 1
| |||
Form 4
| -2.73% | -4.34K |
$4.49 | -$19,496.70 | 154.54K |
Scheduled
|
Nov 16
| ||
Form 4
| -2.53% | -4.12K |
$5.03 | -$20,760.22 | 158.88K |
Scheduled
|
Aug 16
| ||
Form 4
| -2.32% | -3.87K |
$5.32 | -$20,596.61 | 163.01K |
Scheduled
|
May 17
| ||
Form 4
| +84.21% | 76.28K |
$9.86 | -$21,890.18 | 166.88K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$12.79 | -$32,100.00 | 90.59K |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
$12.80 | -$32,150.00 | 90.59K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$13.76 | -$41,788.50 | 90.59K |
Scheduled
|
Dec 1
| ||
Form 4
| -2.37% | -2.20K |
$17.12 | -$37,640.06 | 90.59K |
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$13.00 | -$34,150.00 | 92.79K |
Scheduled
|
Nov 2
| ||
Form 4
| -2.27% | -2.15K |
$12.53 | -$26,968.86 | 92.79K |
Scheduled
|
Aug 17
| ||
Form 4
| -5.18% | -5.18K |
$14.55 | -$75,427.20 | 94.94K |
Scheduled
|
May 18
| ||
Form 4
| +116.50% | 53.88K |
—
|
—
| 100.13K |
Mar 1
| |||
Form 4
|
∞
| 46.25K |
—
|
—
| 46.25K |
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.9657
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 46.5K |
—
|
—
| 46.5K |
Feb 14
| |||
Form 4
|
—
|
0
|
$12.88 | -$181,782.37 |
0
|
Dec 27 - Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apexigen, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OncoMed Pharmaceuticals Inc No price found
SVP & Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pyxis Oncology, Inc. (PYXS) Snapshot price: $3.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 38.74K |
—
|
—
| 38.74K |
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||